ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

5 links2 made here, not in the record4 judgments2 judges (the rules as one: Rule based)1 record change seen
Claude Opus 5.5Rule basedRecord updated on ClinicalTrials.govReplaced, or read an older versionMade here
Sep 28Oct 5Oct 12Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT07846956NAION in Non-Diabetic ObesePatients Using GLP-1Receptor Agonists: AReal-World StudyIstanbul Saglik Bilimleri Univnot yet recruitingRECORDThe record itselfVersions seen nightly since Sep 25, 2…›Sep 29 · ClinicalTrials.gov record · Version of 2026-09-29Version of 2026-09-29CONDITIONSObesityThe registry's MeSH filing›As of now · Rule based · Main conditionMain conditionOptic Neuropathy, IschemicThe registry's MeSH filing›No judgment recorded. Shown as the registry files it.Optic Nerve DiseasesThe registry's MeSH filing›No judgment recorded. Shown as the registry files it.DRUGSSemaglutideMade here · Found by reading; no entr…›Nov 1 · Claude Opus 5.5 · ExposureNov 2 · Claude Opus 5.5 · ExposureExposureTirzepatideMade here · Found by reading; no entr…›Nov 2 · Claude Opus 5.5 · ExposureExposure

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Semaglutide

Made here2 judgments on this link
NCT07846956gives it, found by reading the recordSemaglutideDefined by Claude Opus 5.5Nov 1, 2026, 9:53 AM UTC
Role in the study, from the registry to what was judged
RegistryNot in the recordno intervention entry names it
→judged=agrees
How the 2 judgments split100%of judgments with a known value say Exposure
Exposure · 2

All judgments on this study

WhenLinkJudgeDecisionState
Sep 29The record itselfClinicalTrials.gov recordVersion of 2026-09-29Record change
Nov 1Semaglutidemade hereClaude Opus 5.5ExposureReplaced
Nov 2Semaglutidemade hereClaude Opus 5.5ExposureCurrent
Nov 2Tirzepatidemade hereClaude Opus 5.5ExposureCurrent
As of nowObesityRule based · main-condition ruleMain conditionCurrent

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

What a study is mainly about

Starts from the first condition ClinicalTrials.gov files the study under. It moves to a narrower one only when the study's own title or listed conditions name it, and sets aside terms the registry often files by mistake. A study open to many cancers is not placed under one of them unless its title names it.

Checked against studies judged one by one; the study page says when it differs from the registry.